Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Implementing universal vaccination programmes: Spain

J de la Torre1, R Esteban

  • 1Ministerio de Sanedad y Consumo, Departamento de Enfirmedares Trasmisibles, Madrid, Spain.

Vaccine
|January 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Downed woody debris carbon emissions in a European temperate virgin forest as driven by species, decay classes, diameter and microclimate.

The Science of the total environment·2023
Same author

Efficacy and safety of dolutegravir/rilpivirine in real-world clinical practice. GeSIDA study 1119.

HIV medicine·2023
Same author

Linezolid for infective endocarditis: A structured approach based on a national database experience.

Medicine·2021
Same author

Is the universal population Hepatitis C virus screening a cost-effective strategy? A systematic review of the economic evidence.

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2020
Same author

Effect of sperm dosage transportation in stallions: Effect on sperm DNA fragmentation.

Animal reproduction science·2019
Same author

Safety and Efficacy of Dolutegravir Plus Rilpivirine in Treatment-Experienced HIV-Infected Patients: The DORIVIR Study.

Journal of the International Association of Providers of AIDS Care·2018
Same journal

Immunogenicity and safety of a SARS-CoV-2 recombinant vaccine S-268024 booster vaccination versus NVX-CoV2373: Interim results from a phase 3, multicenter, randomized, observer-blind, active-controlled study.

Vaccine·2026
Same journal

Safety and immunogenicity of a reduced, homologous booster dose of the BNT162b2 mRNA COVID-19 vaccine: a single blind, randomized, non-inferiority follow-up trial.

Vaccine·2026
Same journal

Vaccination policies for healthcare personnel in Europe, 2026.

Vaccine·2026
Same journal

A historical overview of the anti-vaccine movement and its public health implications.

Vaccine·2026
Same journal

Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.

Vaccine·2026
Same journal

Influence of correlated vaccination behaviors on estimates of COVID-19 vaccine effectiveness in older adults - VISION network, October 2023 - March 2024.

Vaccine·2026
See all related articles

Spain

Area of Science:

  • Public Health
  • Epidemiology
  • Vaccinology

Background:

  • The previous selective high-risk vaccination policy for hepatitis B in Spain (pre-1990) was ineffective in reducing disease incidence and chronic carrier rates.
  • Hepatitis B infection poses a significant public health challenge due to its potential for chronic liver disease.

Purpose of the Study:

  • To evaluate the implementation of universal hepatitis B immunization programs in Spain.
  • To document the shift from selective to universal vaccination strategies for adolescents.

Main Methods:

  • The study tracks the adoption of universal hepatitis B vaccination programs across different regions of Spain.
  • Key dates for program initiation in Catalonia and subsequent regions are recorded.

Related Experiment Videos

Main Results:

  • Catalonia initiated a universal hepatitis B immunization program for 12-year-olds in 1991.
  • By 1993, multiple Spanish regions had implemented similar universal vaccination programs targeting adolescents.

Conclusions:

  • Spain transitioned towards a universal hepatitis B vaccination strategy for adolescents.
  • The widespread adoption of these programs aims to improve hepatitis B control nationwide.